Skip to main content

Eczema News

Findings from a recent study showed patients with moderate to severe atopic dermatitis had a high burden of ocular surface disorders and related symptoms.
A synthetic indolicidin analogue antimicrobial peptide with activity against Staphylococcus aureus improved dysbiosis but not the clinical signs of atopic dermatitis.
A recent randomized clinical trial showed baricitinib combined with topical corticosteroids improved the signs and symptoms of moderate to severe atopic dermatitis.
Findings from a recent study showed crisaborole ointment quickly and effectively improved mild to moderate atopic dermatitis among pediatric patients.
Findings from a recent study showed dupilumab was safe and effective for treating treatment-resistant atopic dermatitis over a year in a real-world setting.
A recent review investigated the mechanisms, diagnosis, and management of infectious complications associated with atopic dermatitis, including the use of antibiotics.
Findings from a recent study suggest that topical calcineurin inhibitors are not associated with an increased risk of keratinocyte carcinomas among adult patients with atopic dermatitis.
Findings from two large cohort studies highlighted the potential association between atopic dermatitis (AD), overall and specific cancer risks, and the influence of AD severity on this risk.
A recent meta-analysis and systematic review investigated the effectiveness of systemic treatments for patients with atopic dermatitis, highlighting 2 with potentially better short-term efficacy.
Findings from a recent study showed no association between the use of topical tacrolimus and cancer among pediatric patients with atopic dermatitis.
Back to Top